1. The re-election of President Trump has pushed US stocks to new heights, but his nomination of RFK Jr. for Health and Human Services Secretary has excluded certain pharma and biotech stocks from the 'Trump Bump'.; 2. Market jitters surrounding the next four years of healthcare policy have created buying opportunities for value investors.; 3. The Quant Team has identified two stocks with solid investment fundamentals that present attractive value opportunities in the current sell-off.